Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Codexis Inc

4QK
Current price
3.62 EUR -0.1 EUR (-2.79%)
Last closed 3.76 EUR
Company
ISIN US1920051067
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 312 358 972 EUR
Yield for 12 month +91.19 %
1Y
3Y
5Y
10Y
15Y
4QK
21.11.2021 - 28.11.2021

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

27.89 EUR

P/E ratio

Dividend Yield

Current Year

+66 321 259 EUR

Last Year

+131 038 924 EUR

Current Quarter

+12 133 794 EUR

Last Quarter

+7 544 264 EUR

Current Year

+54 210 157 EUR

Last Year

+95 078 152 EUR

Current Quarter

+8 052 006 EUR

Last Quarter

+4 270 891 EUR

Key Figures 4QK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -46 132 736 EUR
Operating Margin TTM -129.02 %
PE Ratio
Return On Assets TTM -20.95 %
PEG Ratio
Return On Equity TTM -75.31 %
Wall Street Target Price 27.89 EUR
Revenue TTM 64 943 976 EUR
Book Value 0.91 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 38.3 %
Dividend Yield
Gross Profit TTM 20 616 080 EUR
Earnings per share -0.83 EUR
Diluted Eps TTM -0.83 EUR
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -96.35 %

Dividend Analytics 4QK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 4QK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 4QK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 138.8889
Enterprise Value Revenue 4.4103
Price Sales TTM 4.8097
Enterprise Value EBITDA -3.8433
Price Book MRQ 4.4735

Financials 4QK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4QK

For 52 weeks

1.56 EUR 4.26 EUR
50 Day MA 2.84 EUR
Shares Short Prior Month
200 Day MA 2.91 EUR
Short Ratio
Shares Short
Short Percent